Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis
Julie Guillermet‐Guibert(Centre National de la Recherche Scientifique), Corinne Bousquet(Centre National de la Recherche Scientifique), Lucien Pradayrol(Inserm), Christiane Susini(Inserm), Philippe Rochaix(Inserm), Thierry Levade(Inserm), Louis Buscail(Tulane University), Nathalie Saint‐Laurent(Centre National de la Recherche Scientifique), Andrew V. Schally(Tulane University), Olivier Cuvillier(Centre National de la Recherche Scientifique)
Cited by 124
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284